The partnership will further develop P4 Diagnostix’s urology testing services to include somatic testing by integrating the Illumina TruSight Oncology 500 cancer panel, according to a Sept. 28 news release from P4 Diagnostix.
Somatic testing will be incorporated with UroSeq, P4 Diagnostix’s current germline testing product.
The testing will launch at P4 Diagnostix’s laboratory in Indianapolis, the release said.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.